The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
Authors
Keywords
-
Journal
EUROPEAN HEART JOURNAL
Volume 39, Issue 16, Pages 1330-1393
Publisher
Oxford University Press (OUP)
Online
2018-03-02
DOI
10.1093/eurheartj/ehy136
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of the safety and efficacy of an edoxaban-based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST-AF PCI trial
- (2018) Pascal Vranckx et al. AMERICAN HEART JOURNAL
- Safety of Uninterrupted Periprocedural Edoxaban Versus Phenprocoumon for Patients Who Underwent Left Atrial Catheter Ablation Procedures
- (2018) Marc Kottmaier et al. AMERICAN JOURNAL OF CARDIOLOGY
- Clinical Outcomes and History of Fall in Patients with Atrial Fibrillation Treated with Oral Anticoagulation: Insights From the ARISTOTLE Trial
- (2018) Meena P. Rao et al. AMERICAN JOURNAL OF MEDICINE
- Comparing Bleeding Risk Assessment Focused on Modifiable Risk Factors Only Versus Validated Bleeding Risk Scores in Atrial Fibrillation
- (2018) Yutao Guo et al. AMERICAN JOURNAL OF MEDICINE
- Association of prothrombin complex concentrate administration and hematoma enlargement in non-vitamin K antagonist oral anticoagulant-related intracerebral hemorrhage
- (2018) Stefan T. Gerner et al. ANNALS OF NEUROLOGY
- Telemonitoring-based feedback improves adherence to non-vitamin K antagonist oral anticoagulants intake in patients with atrial fibrillation
- (2018) Lien Desteghe et al. EUROPEAN HEART JOURNAL
- Rivaroxaban-induced hepatotoxicity
- (2018) Anna Licata et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Major bleeding and intracranial hemorrhage risk prediction in patients with atrial fibrillation: Attention to modifiable bleeding risk factors or use of a bleeding risk stratification score? A nationwide cohort study
- (2018) Tze-Fan Chao et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Association of Intracerebral Hemorrhage Among Patients Taking Non–Vitamin K Antagonist vs Vitamin K Antagonist Oral Anticoagulants With In-Hospital Mortality
- (2018) Taku Inohara et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Characteristics of Symptomatic Intracerebral Hemorrhage in Patient Receiving Direct Oral Anticoagulants: Comparison with Warfarin
- (2018) Masahito Kawabori et al. Journal of Stroke & Cerebrovascular Diseases
- Relationship of Aging and Incident Comorbidities to Stroke Risk in Patients With Atrial Fibrillation
- (2018) Tze-Fan Chao et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Prestroke Mobility and Dementia as Predictors of Stroke Outcomes in Patients Over 65 Years of Age: A Cohort Study From The Swedish Dementia and Stroke Registries
- (2018) Sara Garcia-Ptacek et al. Journal of the American Medical Directors Association
- Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial
- (2018) Olivier Varenne et al. LANCET
- Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
- (2018) Gary E. Raskob et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging
- (2018) Gregory W. Albers et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct
- (2018) Raul G. Nogueira et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
- (2018) William J. Powers et al. STROKE
- Characteristics of Symptomatic Intracerebral Hemorrhage in Patient Receiving Direct Oral Anticoagulants: Comparison with Warfarin
- (2018) Masahito Kawabori et al. Journal of Stroke & Cerebrovascular Diseases
- P817Effect of individualised education sessions on the knowledge level of patients with atrial fibrillation
- (2017) L. Desteghe et al. EUROPACE
- Frailty syndrome: an emerging clinical problem in the everyday management of clinical arrhythmias. The results of the European Heart Rhythm Association survey
- (2017) Stefano Fumagalli et al. EUROPACE
- Does atrial fibrillation cause cognitive decline and dementia?
- (2017) Joanna Dietzel et al. EUROPACE
- Interruption of non-vitamin K antagonist anticoagulants in patients undergoing planned invasive procedures: how long is long enough?
- (2017) Johann Auer et al. EUROPEAN HEART JOURNAL
- Predictors of pre-procedural concentrations of direct oral anticoagulants: a prospective multicentre study
- (2017) Anne Godier et al. EUROPEAN HEART JOURNAL
- 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
- (2017) Borja Ibanez et al. EUROPEAN HEART JOURNAL
- Less dementia with oral anticoagulation in atrial fibrillation
- (2017) Leif Friberg et al. EUROPEAN HEART JOURNAL
- 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
- (2017) Marco Valgimigli et al. EUROPEAN HEART JOURNAL
- 2017 ESC/EACTS Guidelines for the management of valvular heart disease
- (2017) Helmut Baumgartner et al. EUROPEAN HEART JOURNAL
- The efficacy and safety of direct oral anticoagulants vs traditional anticoagulants in cirrhosis
- (2017) Justine Hum et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Drug-induced liver injury with oral anticoagulants: a threat or not?
- (2017) Tatjana S Potpara et al. HEART
- Prospective study of oral anticoagulants and risk of liver injury in patients with atrial fibrillation
- (2017) Alvaro Alonso et al. HEART
- Early non-persistence with dabigatran and rivaroxaban in patients with atrial fibrillation
- (2017) Cynthia A Jackevicius et al. HEART
- Real-world evidence with apixaban for stroke prevention in patients with nonvalvular atrial fibrillation in Germany: a retrospective study (REASSESS)
- (2017) Craig Ian Coleman et al. Internal and Emergency Medicine
- First experience with edoxaban and atrial fibrillation ablation – Insights from the ENGAGE AF-TIMI 48 trial
- (2017) Jan Steffel et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Body mass index is an independent predictor of major bleeding in non-valvular atrial fibrillation patients taking dabigatran
- (2017) Chen-Hung Lee et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Direct oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation
- (2017) Fernando Dominguez et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Direct oral anti-coagulants compared with vitamin-K inhibitors and low-molecular-weight-heparin for the prevention of venous thromboembolism in patients with cancer: A meta-analysis study
- (2017) Natale Daniele Brunetti et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany – A national case collection
- (2017) Pawel Kermer et al. International Journal of Stroke
- Postapproval Observational Studies of Non–Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation
- (2017) Tatjana S. Potpara et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Comparisons of Interventions for Preventing Falls in Older Adults
- (2017) Andrea C. Tricco et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Increased rates of atrial fibrillation recurrence following pulmonary vein isolation in overweight and obese patients
- (2017) Bhradeev Sivasambu et al. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
- 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary
- (2017) Hugh Calkins et al. JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY
- Intravenous thrombolysis and clot retrieval following reversal of dabigatran with idarucizumab
- (2017) Dominic MY Tse et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice
- (2017) Gargi Banerjee et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial Fibrillation
- (2017) Miney Paquette et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Obesity and Atrial Fibrillation Prevalence, Pathogenesis, and Prognosis
- (2017) Carl J. Lavie et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease
- (2017) Giulia Renda et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial
- (2017) Raffaele De Caterina et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants
- (2017) Gordon F. Tomaselli et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Changing Landscape for Stroke Prevention in AF
- (2017) Menno V. Huisman et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Non–Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction
- (2017) Xiaoxi Yao et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of New Oral Anticoagulants on Prescribing Practices for Atrial Fibrillation in Older Adults
- (2017) Raymond B. Fohtung et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Apixaban Pharmacokinetics at Steady State in Hemodialysis Patients
- (2017) Thomas A. Mavrakanas et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Dissociation between the pharmacokinetics and pharmacodynamics of once-daily rivaroxaban and twice-daily apixaban: a randomized crossover study
- (2017) R. Kreutz et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Reversal of apixaban anticoagulation by four-factor prothrombin complex concentrates in healthy subjects: a randomized three-period crossover study
- (2017) Y. Song et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians
- (2017) J. Douxfils et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial
- (2017) Dragos Vinereanu et al. LANCET
- The future of atrial fibrillation management: integrated care and stratified therapy
- (2017) Paulus Kirchhof LANCET
- Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillation
- (2017) Eleni Korompoki et al. NEUROLOGY
- Outcome of intracerebral hemorrhage associated with different oral anticoagulants
- (2017) Duncan Wilson et al. NEUROLOGY
- Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
- (2017) John W. Eikelboom et al. NEW ENGLAND JOURNAL OF MEDICINE
- Triple Therapy for Atrial Fibrillation after PCI
- (2017) Jonathan P. Piccini et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation
- (2017) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Idarucizumab for Dabigatran Reversal — Full Cohort Analysis
- (2017) Charles V. Pollack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism
- (2017) Jeffrey I. Weitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation
- (2017) Hugh Calkins et al. NEW ENGLAND JOURNAL OF MEDICINE
- Real-World Adherence and Persistence with Direct Oral Anticoagulants in Adults with Atrial Fibrillation
- (2017) Beenish S. Manzoor et al. PHARMACOTHERAPY
- Interventional Spine and Pain Procedures in Patients on Antiplatelet and Anticoagulant Medications (Second Edition)
- (2017) Samer Narouze et al. REGIONAL ANESTHESIA AND PAIN MEDICINE
- Incidence of seizures following initial ischemic stroke in a community-based cohort: The Framingham Heart Study
- (2017) Maria Stefanidou et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Emergency Coagulation Assessment During Treatment With Direct Oral Anticoagulants
- (2017) Matthias Ebner et al. STROKE
- Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation
- (2017) George Ntaios et al. STROKE
- Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation
- (2017) Ying Bai et al. STROKE
- Using Artificial Intelligence to Reduce the Risk of Nonadherence in Patients on Anticoagulation Therapy
- (2017) Daniel L. Labovitz et al. STROKE
- The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale
- (2017) Alex Spyropoulos et al. THROMBOSIS AND HAEMOSTASIS
- Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in “real-world” clinical practice
- (2017) Steve Deitelzweig et al. THROMBOSIS AND HAEMOSTASIS
- Assessing Bleeding Risk in Atrial Fibrillation Patients: Comparing a Bleeding Risk Score Based Only on Modifiable Bleeding Risk Factors against the HAS-BLED Score. The AMADEUS Trial
- (2017) María Esteve-Pastor et al. THROMBOSIS AND HAEMOSTASIS
- Risks of postextraction bleeding after receiving direct oral anticoagulants or warfarin: a retrospective cohort study
- (2017) Takahiro Yagyuu et al. BMJ Open
- Effects of Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: A Systematic Review and Meta‐Analysis
- (2017) Kuo‐Li Pan et al. Journal of the American Heart Association
- Early Recurrence and Major Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation Treated With Non–Vitamin‐K Oral Anticoagulants (RAF‐NOACs) Study
- (2017) Maurizio Paciaroni et al. Journal of the American Heart Association
- Major Bleeding Complications and Persistence With Oral Anticoagulation in Non‐Valvular Atrial Fibrillation: Contemporary Findings in Real‐Life Danish Patients
- (2017) Morten Lamberts et al. Journal of the American Heart Association
- Thromboembolic and bleeding complications during oral anticoagulation therapy in cancer patients with atrial fibrillation: a Danish nationwide population-based cohort study
- (2017) Anne G. Ording et al. Cancer Medicine
- Drug interactions with new oral anticoagulants in elderly patients
- (2017) Claudia Stöllberger Expert Review of Clinical Pharmacology
- Management of direct oral anticoagulants in patients undergoing elective surgeries and invasive procedures: Updated guidelines from the French Working Group on Perioperative Hemostasis (GIHP) – September 2015
- (2017) Pierre Albaladejo et al. Anaesthesia Critical Care & Pain Medicine
- Intravenous Thrombolysis in Patients with Stroke Taking Rivaroxaban Using Drug Specific Plasma Levels: Experience with a Standard Operation Procedure in Clinical Practice
- (2017) David J. Seiffge et al. Journal of Stroke
- Major Bleeding Risk During Anticoagulation with Warfarin, Dabigatran, Apixaban, or Rivaroxaban in Patients with Nonvalvular Atrial Fibrillation
- (2017) Gboyega Adeboyeje et al. Journal of Managed Care & Specialty Pharmacy
- Apixaban compared with parenteral heparin and/or vitamin K antagonist in patients with nonvalvular atrial fibrillation undergoing cardioversion: Rationale and design of the EMANATE trial
- (2016) Michael D. Ezekowitz et al. AMERICAN HEART JOURNAL
- A randomized trial to compare the safety of rivaroxaban vs aspirin in addition to either clopidogrel or ticagrelor in acute coronary syndrome: The design of the GEMINI-ACS-1 phase II study
- (2016) Thomas J. Povsic et al. AMERICAN HEART JOURNAL
- Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF)
- (2016) Gregory Y.H. Lip et al. AMERICAN HEART JOURNAL
- Ischemic and bleeding events in patients with myocardial infarction undergoing percutaneous coronary intervention who require oral anticoagulation: Insights from the Canadian observational AntiPlatelet sTudy
- (2016) Steven Sra et al. AMERICAN HEART JOURNAL
- Anticoagulation, CHA2DS2VASc Score, and Thromboembolic Risk of Cardioversion of Acute Atrial Fibrillation (from the FinCV Study)
- (2016) Toni Grönberg et al. AMERICAN JOURNAL OF CARDIOLOGY
- A Summary of the Literature Evaluating Adherence and Persistence with Oral Anticoagulants in Atrial Fibrillation
- (2016) Kehinde O. Obamiro et al. American Journal of Cardiovascular Drugs
- Effect of Rifampin on the Pharmacokinetics of Apixaban, an Oral Direct Inhibitor of Factor Xa
- (2016) Blisse Vakkalagadda et al. American Journal of Cardiovascular Drugs
- Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease
- (2016) Renato D. Lopes et al. AMERICAN JOURNAL OF MEDICINE
- Mortality in Patients with Atrial Fibrillation Randomized to Edoxaban or Warfarin: Insights from the ENGAGE AF-TIMI 48 Trial
- (2016) Robert P. Giugliano et al. AMERICAN JOURNAL OF MEDICINE
- Effective and safe proton pump inhibitor therapy in acid-related diseases – A position paper addressing benefits and potential harms of acid suppression
- (2016) Carmelo Scarpignato et al. BMC Medicine
- Edoxaban drug-drug interactions with ketoconazole, erythromycin, and cyclosporine
- (2016) Dolly A. Parasrampuria et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Direct Comparison of Dabigatran, Rivaroxaban, and Apixaban for Effectiveness and Safety in Nonvalvular Atrial Fibrillation
- (2016) Peter A. Noseworthy et al. CHEST
- On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With WarfarinClinical Perspective
- (2016) Christopher B. Fordyce et al. CIRCULATION
- Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 TrialClinical Perspective
- (2016) Erin A. Bohula et al. CIRCULATION
- Comparison of Dabigatran and Warfarin in Patients With Atrial Fibrillation and Valvular Heart DiseaseClinical Perspective
- (2016) Michael D. Ezekowitz et al. CIRCULATION
- Cardio-Oncology
- (2016) Carrie G. Lenneman et al. CIRCULATION RESEARCH
- Special considerations for therapeutic choice of non-vitamin K antagonist oral anticoagulants for Japanese patients with nonvalvular atrial fibrillation
- (2016) Ken Okumura et al. CLINICAL CARDIOLOGY
- Sex Differences in the Association Between Regular Physical Activity and Incident Atrial Fibrillation: A Meta-analysis of 13 Prospective Studies
- (2016) Wen-Gen Zhu et al. CLINICAL CARDIOLOGY
- Pragmatic approach to manage new oral anticoagulants in patients undergoing dental extractions: a prospective case-control study
- (2016) Isabel Miclotte et al. Clinical Oral Investigations
- Comparison of Adherence to Rivaroxaban Versus Apixaban Among Patients With Atrial Fibrillation
- (2016) Colleen A. McHorney et al. CLINICAL THERAPEUTICS
- Evaluation of Crushed Tablet for Oral Administration and the Effect of Food on Apixaban Pharmacokinetics in Healthy Adults
- (2016) Yan Song et al. CLINICAL THERAPEUTICS
- Idarucizumab for dabigatran overdose
- (2016) Marijke Peetermans et al. CLINICAL TOXICOLOGY
- Evaluation of SAMe-TT2R2score and other clinical factors influencing the quality of anticoagulation therapy in non-valvular atrial fibrillation: a nationwide study in Spain
- (2016) José M. Lobos-Bejarano et al. CURRENT MEDICAL RESEARCH AND OPINION
- The safety and persistence of non-vitamin-K-antagonist oral anticoagulants in atrial fibrillation patients treated in a well structured atrial fibrillation clinic
- (2016) Faris Al-Khalili et al. CURRENT MEDICAL RESEARCH AND OPINION
- The Complex Role of Anticoagulation in Cirrhosis: An Updated Review of Where We Are and Where We Are Going
- (2016) Tawfik Khoury et al. DIGESTION
- Direct Oral Anticoagulants in Cirrhosis Patients Pose Similar Risks of Bleeding When Compared to Traditional Anticoagulation
- (2016) N. M. Intagliata et al. DIGESTIVE DISEASES AND SCIENCES
- Interactions between non-vitamin K oral anticoagulants and antiepileptic drugs
- (2016) Claudia Stöllberger et al. EPILEPSY RESEARCH
- Rationale and design of AXAFA-AFNET 5: an investigator-initiated, randomized, open, blinded outcome assessment, multi-centre trial to comparing continuous apixaban to vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation
- (2016) Luigi Di Biase et al. EUROPACE
- Real-world persistence and adherence to oral anticoagulation for stroke risk reduction in patients with atrial fibrillation
- (2016) Jan Beyer-Westendorf et al. EUROPACE
- The ‘obesity paradox’ in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial
- (2016) Roopinder K. Sandhu et al. EUROPEAN HEART JOURNAL
- 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
- (2016) Jose Luis Zamorano et al. EUROPEAN HEART JOURNAL
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
- (2016) Paulus Kirchhof et al. EUROPEAN HEART JOURNAL
- Efficacy and safety of edoxaban compared with warfarin in patients with atrial fibrillation and heart failure: insights from ENGAGE AF-TIMI 48
- (2016) Giulia Magnani et al. EUROPEAN JOURNAL OF HEART FAILURE
- Association of Proton Pump Inhibitors With Reduced Risk of Warfarin-Related Serious Upper Gastrointestinal Bleeding
- (2016) Wayne A. Ray et al. GASTROENTEROLOGY
- Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation
- (2016) A John Camm et al. HEART
- Medication adherence to rivaroxaban and dabigatran for stroke prevention in patients with non-valvular atrial fibrillation in the United States
- (2016) Craig I. Coleman et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Knowledge gaps in patients with atrial fibrillation revealed by a new validated knowledge questionnaire
- (2016) Lien Desteghe et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Association between once- and twice-daily direct oral anticoagulant adherence in nonvalvular atrial fibrillation patients and rates of ischemic stroke
- (2016) Mark J. Alberts et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and valvular heart disease
- (2016) Peter A. Noseworthy et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Impact of once- or twice-daily dosing frequency on adherence to chronic cardiovascular disease medications: A meta-regression analysis
- (2016) Erin R. Weeda et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The Importance of Patient-Specific Factors for Hepatic Drug Response and Toxicity
- (2016) Volker Lauschke et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- An evidence summary of the management of patients taking direct oral anticoagulants (DOACs) undergoing dental surgery
- (2016) S. Johnston INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
- Measuring non-vitamin K antagonist oral anticoagulant levels: When is it appropriate and which methods should be used?
- (2016) Ludovic Drouet et al. International Journal of Stroke
- Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke: A Meta-analysis
- (2016) Jeffrey L. Saver et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Meta-analysis of efficacy and safety of apixaban and uninterrupted apixaban therapy compared to vitamin K antagonists in patients undergoing catheter ablation for atrial fibrillation
- (2016) Anene Ukaigwe et al. JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY
- Stroke and Bleeding Risks in NOAC- and Warfarin-Treated Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation
- (2016) Peter A. Noseworthy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of Falling
- (2016) Jan Steffel et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Obesity and risk of bleeding: the SMART study.
- (2016) S. K. Braekkan et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- To measure or not to measure direct oral anticoagulants before surgery or invasive procedures: reply
- (2016) A. Tripodi JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Bleeding risk assessment in atrial fibrillation: observations on the use and misuse of bleeding risk scores
- (2016) G. Y. H. Lip et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH
- (2016) J. H. Levy et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH
- (2016) K. Martin et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment
- (2016) Allison E. Burnett et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial
- (2016) Andreas Goette et al. LANCET
- The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study
- (2016) Ziad Hijazi et al. LANCET
- Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI
- (2016) C. Michael Gibson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors
- (2016) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reduced Anticoagulant Effect of Dabigatran in a Patient Receiving Concomitant Phenytoin
- (2016) Barbara S. Wiggins et al. PHARMACOTHERAPY
- Safety of Endovascular Thrombectomy in Patients Receiving Non–Vitamin K Antagonist Oral Anticoagulants
- (2016) Jan C. Purrucker et al. STROKE
- Coagulation Testing in Acute Ischemic Stroke Patients Taking Non–Vitamin K Antagonist Oral Anticoagulants
- (2016) Jan C. Purrucker et al. STROKE
- Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC
- (2016) Anja Katholing et al. THROMBOSIS AND HAEMOSTASIS
- Rivaroxaban real-world evidence: Validating safety and effectiveness in clinical practice
- (2016) A. Camm et al. THROMBOSIS AND HAEMOSTASIS
- Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin
- (2016) Allison Keshishian et al. THROMBOSIS AND HAEMOSTASIS
- Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial
- (2016) Jeroen Jaspers Focks et al. BMJ-British Medical Journal
- Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
- (2016) Torben Bjerregaard Larsen et al. BMJ-British Medical Journal
- Management of dental extraction in patients undergoing anticoagulant oral direct treatment: a pilot study
- (2016) Cédric Mauprivez et al. Oral Surgery Oral Medicine Oral Pathology Oral Radiology
- Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial
- (2016) Jeroen Jaspers Focks et al. BMJ-British Medical Journal
- Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
- (2016) Torben Bjerregaard Larsen et al. BMJ-British Medical Journal
- Increased Peripheral Arterial Calcification in Patients Receiving Warfarin
- (2016) Kum Hyun Han et al. Journal of the American Heart Association
- An Integrated Management Approach to Atrial Fibrillation
- (2016) Lindsey Carter et al. Journal of the American Heart Association
- Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF–TIMI 48 Trial
- (2016) Eri Toda Kato et al. Journal of the American Heart Association
- Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation
- (2016) Xiaoxi Yao et al. Journal of the American Heart Association
- Concomitant Use of Single Antiplatelet Therapy With Edoxaban or Warfarin in Patients With Atrial Fibrillation: Analysis From the ENGAGE AF‐TIMI48 Trial
- (2016) Haiyan Xu et al. Journal of the American Heart Association
- Management and outcomes of vaginal bleeding and heavy menstrual bleeding in women of reproductive age on direct oral anti-factor Xa inhibitor therapy: a case series
- (2016) Jan Beyer-Westendorf et al. Lancet Haematology
- Mobile Phone Apps to Improve Medication Adherence: A Systematic Stepwise Process to Identify High-Quality Apps
- (2016) Karla Santo et al. JMIR mHealth and uHealth
- Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention in Incident, Treatment-Naïve Nonvalvular Atrial Fibrillation
- (2016) Joshua D. Brown et al. Journal of Managed Care & Specialty Pharmacy
- Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine
- (2016) John H. Alexander et al. JAMA Cardiology
- Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation in Relation to Renal Function Over Time
- (2016) Ziad Hijazi et al. JAMA Cardiology
- Impact of advanced age on management and prognosis in atrial fibrillation: insights from a population-based study in general practice
- (2015) Andreas Wolff et al. AGE AND AGEING
- Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial
- (2015) Christopher B. Granger et al. AMERICAN HEART JOURNAL
- An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin k antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI)
- (2015) C. Michael Gibson et al. AMERICAN HEART JOURNAL
- Comparison of Safety of Left Atrial Catheter Ablation Procedures for Atrial Arrhythmias Under Continuous Anticoagulation With Apixaban Versus Phenprocoumon
- (2015) Bernhard M. Kaess et al. AMERICAN JOURNAL OF CARDIOLOGY
- Dose-Finding Study of Rivaroxaban in Hemodialysis Patients
- (2015) An S. De Vriese et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective ‘Real-world’ Inception Cohort Study
- (2015) Vanessa Roldán et al. AMERICAN JOURNAL OF MEDICINE
- Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use
- (2015) I. Martinelli et al. BLOOD
- Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor
- (2015) Charles E. Frost et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Intracranial Hemorrhage and Subsequent Ischemic Stroke in Patients With Atrial Fibrillation
- (2015) Peter Brønnum Nielsen et al. CHEST
- Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart DiseaseCLINICAL PERSPECTIVE
- (2015) Alvaro Avezum et al. CIRCULATION
- Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial FibrillationCLINICAL PERSPECTIVE
- (2015) Jonathan P. Piccini et al. CIRCULATION
- Patient Guide for Taking the Non-Vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation
- (2015) D. A. Lane et al. CIRCULATION
- Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis
- (2015) K. E. Chan et al. CIRCULATION
- Short-Term Safety and Plasma Concentrations of Edoxaban in Japanese Patients With Non-Valvular Atrial Fibrillation and Severe Renal Impairment
- (2015) Yukihiro Koretsune et al. CIRCULATION JOURNAL
- Polypharmacy and major adverse events in atrial fibrillation: observations from the AFFIRM trial
- (2015) Marco Proietti et al. Clinical Research in Cardiology
- Relative Bioavailability of Apixaban Solution or Crushed Tablet Formulations Administered by Mouth or Nasogastric Tube in Healthy Subjects
- (2015) Yan Song et al. CLINICAL THERAPEUTICS
- Pharmacy quality alliance measure: adherence to non-warfarin oral anticoagulant medications
- (2015) Concetta Crivera et al. CURRENT MEDICAL RESEARCH AND OPINION
- Adherence to non-vitamin-K-antagonist oral anticoagulant medications based on the Pharmacy Quality Alliance measure
- (2015) Colleen A. McHorney et al. CURRENT MEDICAL RESEARCH AND OPINION
- Anticoagulation reversal in the era of the non-vitamin K oral anticoagulants
- (2015) Andres Enriquez et al. EUROPACE
- Evaluation of SAMe-TT2R2 risk score for predicting the quality of anticoagulation control in a real-world cohort of patients with non-valvular atrial fibrillation on vitamin-K antagonists
- (2015) R. R.-Y. Abumuaileq et al. EUROPACE
- Drug persistence with rivaroxaban therapy in atrial fibrillation patients--results from the Dresden non-interventional oral anticoagulation registry
- (2015) J. Beyer-Westendorf et al. EUROPACE
- Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)
- (2015) Deirdre A. Lane et al. EUROPACE
- Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS)
- (2015) Christian Sticherling et al. EUROPACE
- Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation
- (2015) Hein Heidbuchel et al. EUROPACE
- Non-vitamin K antagonist oral anticoagulants: considerations on once- vs. twice-daily regimens and their potential impact on medication adherence
- (2015) B. Vrijens et al. EUROPACE
- Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trial
- (2015) J. Steffel et al. EUROPEAN HEART JOURNAL
- Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation
- (2015) Riccardo Cappato et al. EUROPEAN HEART JOURNAL
- 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
- (2015) Marco Roffi et al. EUROPEAN HEART JOURNAL
- Comparison of treatment persistence with different oral anticoagulants in patients with atrial fibrillation
- (2015) Tomas Forslund et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Prevention of Dabigatran-Related Gastrointestinal Bleeding With Gastroprotective Agents: A Population-Based Study
- (2015) Esther W. Chan et al. GASTROENTEROLOGY
- Feasibility and safety of uninterrupted periprocedural apixaban administration in patients undergoing radiofrequency catheter ablation for atrial fibrillation: Results from a multicenter study
- (2015) Luigi Di Biase et al. HEART RHYTHM
- Mechanical thrombectomy in acute ischemic stroke: Consensus statement by ESO-Karolinska Stroke Update 2014/2015, supported by ESO, ESMINT, ESNR and EAN
- (2015) Nils Wahlgren et al. International Journal of Stroke
- Anticoagulant Reversal, Blood Pressure Levels, and Anticoagulant Resumption in Patients With Anticoagulation-Related Intracerebral Hemorrhage
- (2015) Joji B. Kuramatsu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Site-Level Variation in and Practices Associated With Dabigatran Adherence
- (2015) Supriya Shore et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end-stage renal disease on hemodialysis
- (2015) Xiaoli Wang et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Choosing the right drug to fit the patient when selecting oral anticoagulation for stroke prevention in atrial fibrillation
- (2015) A. M. Shields et al. JOURNAL OF INTERNAL MEDICINE
- Changes in Renal Function in Patients With Atrial Fibrillation
- (2015) Michael Böhm et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH
- (2015) G. D. Barnes et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nationwide cohort study
- (2015) A. Gorst-Rasmussen et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Laboratory measurement of the anticoagulant activity of edoxaban: a systematic review
- (2015) Adam Cuker et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial
- (2015) Christian T Ruff et al. LANCET
- Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial
- (2015) Marco Valgimigli et al. LANCET
- Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation
- (2015) James D. Douketis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk
- (2015) Philip Urban et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
- (2015) Marc P. Bonaca et al. NEW ENGLAND JOURNAL OF MEDICINE
- Managing dentoalveolar surgical procedures in patients taking new oral anticoagulants
- (2015) Stefano Sivolella et al. Odontology
- Interventional Spine and Pain Procedures in Patients on Antiplatelet and Anticoagulant Medications
- (2015) Samer Narouze et al. REGIONAL ANESTHESIA AND PAIN MEDICINE
- Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation
- (2015) Maurizio Paciaroni et al. STROKE
- Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
- (2015) J. Claude Hemphill et al. STROKE
- Validation of the SAMe-TT2R2 score in a nationwide population of nonvalvular atrial fibrillation patients on vitamin K antagonists
- (2015) Vicente Bertomeu et al. THROMBOSIS AND HAEMOSTASIS
- Pharmacokinetics, safety, and tolerability of edoxaban in end-stage renal disease subjects undergoing haemodialysis
- (2015) Thomas Marbury et al. THROMBOSIS AND HAEMOSTASIS
- Peri-procedural use of rivaroxaban in elective percutaneous coronary intervention to treat stable coronary artery disease
- (2015) Pascal Vranckx et al. THROMBOSIS AND HAEMOSTASIS
- Genotype-guided versus standard vitamin K antagonist dosing algorithms in patients initiating anticoagulation
- (2015) Emilie Belley-Cote et al. THROMBOSIS AND HAEMOSTASIS
- Comparison of dosing algorithms for acenocoumarol and phenprocoumon using clinical factors with the standard care in the Netherlands
- (2015) Yumao Zhang et al. THROMBOSIS RESEARCH
- Treatment of venous thromboembolism in patients with cancer: A network meta-analysis comparing efficacy and safety of anticoagulants
- (2015) Florian Posch et al. THROMBOSIS RESEARCH
- Gastrointestinal bleeding in patients receiving oral anticoagulation: Current treatment and pharmacological perspectives
- (2015) Alessandro Di Minno et al. THROMBOSIS RESEARCH
- Abnormal uterine bleeding in VTE patients treated with rivaroxaban compared to vitamin K antagonists
- (2015) Nico De Crem et al. THROMBOSIS RESEARCH
- Adherence to a Novel Oral Anticoagulant Among Patients with Atrial Fibrillation
- (2015) Meijia Zhou et al. Journal of Managed Care & Specialty Pharmacy
- Adherence to dabigatran therapy and longitudinal patient outcomes: Insights from the Veterans Health Administration
- (2014) Supriya Shore et al. AMERICAN HEART JOURNAL
- Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry
- (2014) J. Beyer-Westendorf et al. BLOOD
- Evaluation of the effect of naproxen on the pharmacokinetics and pharmacodynamics of apixaban
- (2014) Charles Frost et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Intermittent haemodialysis and continuous veno-venous dialysis are effective in mitigating major bleeding due to dabigatran
- (2014) Bartlomiej Getta et al. BRITISH JOURNAL OF HAEMATOLOGY
- Warfarin Use and the Risk for Stroke and Bleeding in Patients With Atrial Fibrillation Undergoing Dialysis
- (2014) Mitesh Shah et al. CIRCULATION
- Periprocedural Stroke and Bleeding Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation With Different Anticoagulation Management
- (2014) Luigi Di Biase et al. CIRCULATION
- Efficacy and Safety of Rivaroxaban Compared With Warfarin Among Elderly Patients With Nonvalvular Atrial Fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)
- (2014) Jonathan L. Halperin et al. CIRCULATION
- 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2014) Craig T. January et al. CIRCULATION
- Stratifying the Risks of Oral Anticoagulation in Patients With Liver Disease
- (2014) Lydia M. Efird et al.
- Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients
- (2014) François Laliberté et al. CURRENT MEDICAL RESEARCH AND OPINION
- Medication persistence and discontinuation of rivaroxaban versus warfarin among patients with non-valvular atrial fibrillation
- (2014) Winnie W. Nelson et al. CURRENT MEDICAL RESEARCH AND OPINION
- Best Practice for Atrial Fibrillation Patient Education
- (2014) Deirdre Lane et al. CURRENT PHARMACEUTICAL DESIGN
- Thromboembolic risk in 16 274 atrial fibrillation patients undergoing direct current cardioversion with and without oral anticoagulant therapy
- (2014) Morten Lock Hansen et al. EUROPACE
- Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial
- (2014) S. Halvorsen et al. EUROPEAN HEART JOURNAL
- Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation
- (2014) Riccardo Cappato et al. EUROPEAN HEART JOURNAL
- Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial
- (2014) J. P. Piccini et al. EUROPEAN HEART JOURNAL
- Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial
- (2014) Günter Breithardt et al. EUROPEAN HEART JOURNAL
- Balancing stroke and bleeding risks in patients with atrial fibrillation and renal failure: the Swedish Atrial Fibrillation Cohort study
- (2014) Leif Friberg et al. EUROPEAN HEART JOURNAL
- Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry
- (2014) J. Beyer-Westendorf et al. EUROPEAN HEART JOURNAL
- 2014 ESC/EACTS Guidelines on myocardial revascularization
- (2014) EUROPEAN HEART JOURNAL
- Edoxaban population pharmacokinetics and exposure–response analysis in patients with non-valvular atrial fibrillation
- (2014) Ophelia Q. P. Yin et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Risk of drug-induced liver injury with the new oral anticoagulants: systematic review and meta-analysis
- (2014) Daniel Caldeira et al. HEART
- Prolonged anticoagulant activity of rivaroxaban in a polymorbid elderly female with non-convulsive epileptic state
- (2014) Claudia Stöllberger et al. HEART & LUNG
- Physical activity and incidence of atrial fibrillation: A systematic review and meta-analysis
- (2014) Chun Shing Kwok et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Time to Cardioversion for Acute Atrial Fibrillation and Thromboembolic Complications
- (2014) Ilpo Nuotio et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Transition of Patients From Blinded Study Drug to Open-Label Anticoagulation
- (2014) Christian T. Ruff et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Net Clinical Benefit of Antithrombotic Therapy in Patients With Atrial Fibrillation and Chronic Kidney Disease
- (2014) Anders Nissen Bonde et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin
- (2014) Elaine M. Hylek et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Rivaroxaban presents a better pharmacokinetic profile than dabigatran in an obese non-diabetic stroke patient
- (2014) Apostolos Safouris et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Comparison of three-factor and four-factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers
- (2014) M. Levi et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
- (2014) Laura Mauri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Use of PER977 to Reverse the Anticoagulant Effect of Edoxaban
- (2014) Jack E. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Point-of-Care Coagulation Testing for Assessment of the Pharmacodynamic Anticoagulant Effect of Direct Oral Anticoagulant
- (2014) Helen Mani et al. THERAPEUTIC DRUG MONITORING
- Safety and Efficacy of Edoxaban, an Oral Factor Xa Inhibitor, Versus Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty: The STARS E-3 Trial
- (2014) Takeshi Fuji et al. THROMBOSIS RESEARCH
- Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety
- (2014) J. Poeran et al. BMJ-British Medical Journal
- Genotype-Guided vs Clinical Dosing of Warfarin and Its Analogues
- (2014) Kathleen Stergiopoulos et al. JAMA Internal Medicine
- Intracranial Hemorrhage and Novel Anticoagulants for Atrial Fibrillation: What Have We Learned?
- (2014) Graeme J. Hankey Current Cardiology Reports
- Drug-Drug Interaction Studies of Cardiovascular Drugs Involving P-Glycoprotein, an Efflux Transporter, on the Pharmacokinetics of Edoxaban, an Oral Factor Xa Inhibitor
- (2013) Jeanne Mendell et al. American Journal of Cardiovascular Drugs
- A New Equation to Estimate Glomerular Filtration Rate
- (2013) Andrew S. Levey et al. ANNALS OF INTERNAL MEDICINE
- Expert consensus of the French Society of Geriatrics and Gerontology and the French Society of Cardiology on the management of atrial fibrillation in elderly people
- (2013) Olivier Hanon et al. Archives of Cardiovascular Diseases
- Effect of extremes of body weight on the pharmacokinetics, pharmacodynamics, safety and tolerability of apixaban in healthy subjects
- (2013) Vijay V. Upreti et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Effect of hepatic impairment on the pharmacokinetics and pharmacodynamics of a single dose of rivaroxaban, an oral, direct Factor Xa inhibitor
- (2013) Dagmar Kubitza et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Co-administration of rivaroxaban with drugs that share its elimination pathways: pharmacokinetic effects in healthy subjects
- (2013) Wolfgang Mueck et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Factors Affecting Quality of Anticoagulation Control Among Patients With Atrial Fibrillation on Warfarin
- (2013) Stavros Apostolakis et al. CHEST
- Management and Outcomes of Major Bleeding During Treatment With Dabigatran or Warfarin
- (2013) Ammar Majeed et al. CIRCULATION
- Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation
- (2013) Ziad Hijazi et al. CIRCULATION
- Use of Dabigatran for Periprocedural Anticoagulation in Patients Undergoing Catheter Ablation for Atrial Fibrillation
- (2013) Mohamed Bassiouny et al. Circulation-Arrhythmia and Electrophysiology
- Higher Persistence in Newly Diagnosed Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran Versus Warfarin
- (2013) Martin Zalesak et al.
- Efficacy and Safety of Rivaroxaban in Patients With Heart Failure and Nonvalvular Atrial Fibrillation
- (2013) Sean van Diepen et al. Circulation-Heart Failure
- Left Ventricular Systolic Dysfunction, Heart Failure, and the Risk of Stroke and Systemic Embolism in Patients With Atrial Fibrillation
- (2013) John J.V. McMurray et al. Circulation-Heart Failure
- Clinical Pharmacokinetic and Pharmacodynamic Profile of Rivaroxaban
- (2013) Wolfgang Mueck et al. CLINICAL PHARMACOKINETICS
- European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation
- (2013) Hein Heidbuchel et al. EUROPACE
- Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial
- (2013) J. H. Alexander et al. EUROPEAN HEART JOURNAL
- A proposal for interdisciplinary, nurse-coordinated atrial fibrillation expert programmes as a way to structure daily practice
- (2013) Dana Berti et al. EUROPEAN HEART JOURNAL
- New oral anticoagulants in addition to single or dual antiplatelet therapy after an acute coronary syndrome: a systematic review and meta-analysis
- (2013) J. Oldgren et al. EUROPEAN HEART JOURNAL
- Effect of Weight Reduction and Cardiometabolic Risk Factor Management on Symptom Burden and Severity in Patients With Atrial Fibrillation
- (2013) Hany S. Abed et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Outcomes After Cardioversion and Atrial Fibrillation Ablation in Patients Treated With Rivaroxaban and Warfarin in the ROCKET AF Trial
- (2013) Jonathan P. Piccini et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Efficacy and Safety of Dabigatran Etexilate and Warfarin in “Real-World” Patients With Atrial Fibrillation
- (2013) Torben Bjerregaard Larsen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Outcomes of Discontinuing Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial Fibrillation
- (2013) Manesh R. Patel et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Efficacy and Safety of Apixaban in Patients After Cardioversion for Atrial Fibrillation
- (2013) Greg Flaker et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients
- (2013) Paul A. Reilly et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Insights Into Onco-Cardiology
- (2013) Dimitrios Farmakis et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial
- (2013) Willem JM Dewilde et al. LANCET
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
- (2013) Christian T Ruff et al. LANCET
- Ischemic Stroke in an Obese Patient Receiving Dabigatran
- (2013) Lorenz Breuer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation
- (2013) David H. Birnie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism
- (2013) Sam Schulman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Apixaban for the Treatment of Acute Venous Thromboembolism
- (2013) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- New Oral Anticoagulants and the Cancer Patient
- (2013) N. J. Short et al. ONCOLOGIST
- Preventing Stroke in Patients With Chronic Kidney Disease and Atrial Fibrillation
- (2013) Holger Reinecke et al. STROKE
- Impact of apixaban on routine and specific coagulation assays: a practical laboratory guide
- (2013) Christian Chatelain et al. THROMBOSIS AND HAEMOSTASIS
- Patient outcomes using the European label for dabigatran
- (2013) Andreas Clemens et al. THROMBOSIS AND HAEMOSTASIS
- A randomised study of dabigatran in elective percutaneous coronary intervention in stable coronary artery disease patients
- (2013) Pascal Vranckx et al. EuroIntervention
- Impact of Daily Dosing Frequency on Adherence to Chronic Medications Among Nonvalvular Atrial Fibrillation Patients
- (2012) François Laliberté et al. ADVANCES IN THERAPY
- Interpretation of Point-of-care INR Results in Patients Treated with Dabigatran
- (2012) Joanne van Ryn et al. AMERICAN JOURNAL OF MEDICINE
- Atrial Fibrillation and Acute Myocardial Infarction: Antithrombotic Therapy and Outcomes
- (2012) Renato D. Lopes et al. AMERICAN JOURNAL OF MEDICINE
- Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding
- (2012) T. E. Warkentin et al. BLOOD
- Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in Atrial Fibrillation Patients Following Myocardial Infarction and Coronary Intervention
- (2012) Morten Lamberts et al. CIRCULATION
- Myocardial Ischemic Events in Patients With Atrial Fibrillation Treated With Dabigatran or Warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial
- (2012) Stefan H. Hohnloser et al. CIRCULATION
- Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin
- (2012) Jeff S. Healey et al. CIRCULATION
- Variation in Warfarin Dose Adjustment Practice Is Responsible for Differences in the Quality of Anticoagulation Control Between Centers and Countries
- (2012) Harriette G.C. Van Spall et al. CIRCULATION
- Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial
- (2012) Antonio L. Dans et al. CIRCULATION
- Rivaroxaban vs. Warfarin in Japanese Patients With Atrial Fibrillation
- (2012) Masatsugu Hori et al. CIRCULATION JOURNAL
- A clinical decision aid for the selection of antithrombotic therapy for the prevention of stroke due to atrial fibrillation
- (2012) Stephen Andrew LaHaye et al. EUROPEAN HEART JOURNAL
- Apixaban in renal insufficiency: successful navigation between the Scylla and Charybdis
- (2012) J. Steffel et al. EUROPEAN HEART JOURNAL
- Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial
- (2012) Stefan H. Hohnloser et al. EUROPEAN HEART JOURNAL
- Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation
- (2012) J. M. L. Hendriks et al. EUROPEAN HEART JOURNAL
- Incident thromboembolism and heart failure associated with new-onset atrial fibrillation in cancer patients
- (2012) Yu-feng Hu et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Reversal of dabigatran anticoagulation by prothrombin complex concentrate (Beriplex P/N) in a rabbit model
- (2012) I. PRAGST et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Comparison of initial warfarin response in obese patients versus non-obese patients
- (2012) Jessica L. Wallace et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease
- (2012) Jonas Bjerring Olesen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban for Extended Treatment of Venous Thromboembolism
- (2012) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of dabigatran on a large panel of routine or specific coagulation assays
- (2012) Séverine Robert et al. THROMBOSIS AND HAEMOSTASIS
- Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: Resolving uncertainties in routine practice
- (2012) Gregory Y. H. Lip et al. THROMBOSIS AND HAEMOSTASIS
- Modelling and simulation of edoxaban exposure and response relationships in patients with atrial fibrillation
- (2012) Jeanne Mendell et al. THROMBOSIS AND HAEMOSTASIS
- Assessment of the impact of rivaroxaban on coagulation assays: Laboratory recommendations for the monitoring of rivaroxaban and review of the literature
- (2012) Jonathan Douxfils et al. THROMBOSIS RESEARCH
- Risk of Venous Thromboembolism in Patients with Cancer: A Systematic Review and Meta-Analysis
- (2012) Freesia Horsted et al. PLOS MEDICINE
- The transport of antiepileptic drugs by P-glycoprotein
- (2011) Chunbo Zhang et al. ADVANCED DRUG DELIVERY REVIEWS
- Evaluation of Prothrombin Complex Concentrate and Recombinant Activated Factor VII to Reverse Rivaroxaban in a Rabbit Model
- (2011) Anne Godier et al. ANESTHESIOLOGY
- Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation
- (2011) John W. Eikelboom et al. CIRCULATION
- Dabigatran Versus Warfarin in Patients With Atrial Fibrillation
- (2011) Rangadham Nagarakanti et al. CIRCULATION
- Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate
- (2011) Elise S. Eerenberg et al. CIRCULATION
- Warfarin in Atrial Fibrillation Patients with Moderate Chronic Kidney Disease
- (2011) R. G. Hart et al. Clinical Journal of the American Society of Nephrology
- Rivaroxaban
- (2011) Wolfgang Mueck et al. CLINICAL PHARMACOKINETICS
- Menstrual problems and contraception in women of reproductive age receiving oral anticoagulation
- (2011) Farah Yasmine Huq et al. CONTRACEPTION
- Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment
- (2011) K. A. A. Fox et al. EUROPEAN HEART JOURNAL
- Loading and maintenance dose algorithms for phenprocoumon and acenocoumarol using patient characteristics and pharmacogenetic data
- (2011) Rianne M.F. van Schie et al. EUROPEAN HEART JOURNAL
- In Vitro and In Vivo P-Glycoprotein Transport Characteristics of Rivaroxaban
- (2011) M. J. Gnoth et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial
- (2011) K.-H. LIESENFELD et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents
- (2011) M. LEVI et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate
- (2011) Sergey V. Brodsky et al. KIDNEY INTERNATIONAL
- Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)
- (2011) Charles A. Herzog et al. KIDNEY INTERNATIONAL
- A case-control study of calciphylaxis in Japanese end-stage renal disease patients
- (2011) M. Hayashi et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Incidence and predictors of acute symptomatic seizures after stroke
- (2011) E. Beghi et al. NEUROLOGY
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
- (2011) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Exposure to CYP3A4-inducing and CYP3A4-non-inducing antiepileptic agents and the risk of fractures
- (2011) Hedi Schelleman et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Hemostatic Therapy in Experimental Intracerebral Hemorrhage Associated With the Direct Thrombin Inhibitor Dabigatran
- (2011) Wei Zhou et al. STROKE
- Left Atrial Catheter Ablation and Ischemic Stroke
- (2011) Karl Georg Haeusler et al. STROKE
- Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II)
- (2011) Ola Dahl et al. THROMBOSIS AND HAEMOSTASIS
- Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation–Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF–TIMI 48)
- (2010) Christian T. Ruff et al. AMERICAN HEART JOURNAL
- Chronic kidney disease and prevalent atrial fibrillation: The Chronic Renal Insufficiency Cohort (CRIC)
- (2010) Elsayed Z. Soliman et al. AMERICAN HEART JOURNAL
- Risk Factors for Atrial Fibrillation After Lung Cancer Surgery: Analysis of The Society of Thoracic Surgeons General Thoracic Surgery Database
- (2010) Mark Onaitis et al. ANNALS OF THORACIC SURGERY
- Influence of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate
- (2010) Joachim Stangier et al. CLINICAL PHARMACOKINETICS
- Incidence of left atrial thrombus prior to atrial fibrillation ablation: is pre-procedural transoesophageal echocardiography mandatory?
- (2010) J. W. McCready et al. EUROPACE
- Clinical Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Factor Xa Inhibitor Edoxaban in Healthy Volunteers
- (2010) Koichiro Ogata et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Effects of Food on the Pharmacokinetics of Edoxaban, an Oral Direct Factor Xa Inhibitor, in Healthy Volunteers
- (2010) Jeanne Mendell et al. JOURNAL OF CLINICAL PHARMACOLOGY
- The Development and Validation of a Brief Performance-Based Fall Risk Assessment Tool for Use in Primary Care
- (2010) A. Tiedemann et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial
- (2010) Lars Wallentin et al. LANCET
- Oral Rivaroxaban for Symptomatic Venous Thromboembolism
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Assays for Measuring Rivaroxaban: Their Suitability and Limitations
- (2010) Edelgard Lindhoff-Last et al. THERAPEUTIC DRUG MONITORING
- Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
- (2010) Joachim Stangier et al. THROMBOSIS AND HAEMOSTASIS
- Apixaban versus enoxaparin in patients with total knee arthroplasty
- (2010) Jiahao Huang et al. THROMBOSIS AND HAEMOSTASIS
- A Frailty Instrument for primary care: findings from the Survey of Health, Ageing and Retirement in Europe (SHARE)
- (2010) Roman Romero-Ortuno et al. BMC Geriatrics
- Close bidirectional relationship between chronic kidney disease and atrial fibrillation: The Niigata preventive medicine study
- (2009) Hiroshi Watanabe et al. AMERICAN HEART JOURNAL
- Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome
- (2009) CIRCULATION
- Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial Fibrillation
- (2009) Alan S. Go et al. CIRCULATION
- Pharmacokinetics and Pharmacodynamics of the Direct Oral Thrombin Inhibitor Dabigatran in Healthy Elderly Subjects
- (2009) Joachim Stangier et al. CLINICAL PHARMACOKINETICS
- In Vitro Assessment of Metabolic Drug-Drug Interaction Potential of Apixaban through Cytochrome P450 Phenotyping, Inhibition, and Induction Studies
- (2009) L. Wang et al. DRUG METABOLISM AND DISPOSITION
- Is a first acute symptomatic seizure epilepsy? Mortality and risk for recurrent seizure
- (2009) Dale C. Hesdorffer et al. EPILEPSIA
- Introducing a new entity: chemotherapy-induced arrhythmia
- (2009) M. Guglin et al. EUROPACE
- Role of the CHADS2Score in the Evaluation of Thromboembolic Risk in Patients With Atrial Fibrillation Undergoing Transesophageal Echocardiography Before Pulmonary Vein Isolation
- (2009) Sarinya Puwanant et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial
- (2009) Alexander GG Turpie et al. LANCET
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
- (2009) Sam Schulman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chronic atrial fibrillation: Incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme
- (2008) Stephan Rietbrock et al. AMERICAN HEART JOURNAL
- Dose-escalation study of the pharmacokinetics and pharmacodynamics of rivaroxaban in healthy elderly subjects
- (2008) Dagmar Kubitza et al. CURRENT MEDICAL RESEARCH AND OPINION
- Apixaban Metabolism and Pharmacokinetics after Oral Administration to Humans
- (2008) N. Raghavan et al. DRUG METABOLISM AND DISPOSITION
- Safety of percutaneous coronary intervention during uninterrupted oral anticoagulant treatment
- (2008) P. P. Karjalainen et al. EUROPEAN HEART JOURNAL
- Incidence and Predictors of Left Atrial Thrombus Prior to Catheter Ablation of Atrial Fibrillation
- (2008) DANIEL SCHERR et al. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
- Effective Exercise for the Prevention of Falls: A Systematic Review and Meta-Analysis
- (2008) Catherine Sherrington et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Dilemmas in the Management of Atrial Fibrillation in Chronic Kidney Disease
- (2008) H. Reinecke et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial
- (2008) Ajay K Kakkar et al. LANCET
- Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
- (2008) Bengt I. Eriksson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty
- (2008) Michael R. Lassen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Calciphylaxis: Emerging Concepts in Prevention, Diagnosis, and Treatment
- (2003) William A Wilmer et al. SEMINARS IN DIALYSIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More